Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 1

Status

Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2

Conditions

Opioid-Induced Constipation 2Constipation 2

Interventions

naloxegol 5Metformin 4alvimopan 3Radiotherapy 3tegaserod 2Testosterone Propionate 2Surveys and Questionnaires 2Standard of Care 2Liraglutide 2Glutamine 2Fibroblast Growth Factor 7 2Exenatide 2Early Intervention, Educational 2semaglutide 1prucalopride 1oxycodone-acetaminophen 1oxycodone naloxone combination 1lime 1dapagliflozin 1cyclohexaneacetic acid 1bicalutamide 1acetaminophen, hydrocodone drug combination 1Testosterone 1Taxes 1Tamoxifen 1Tadalafil 1Sugars 1Sugammadex 1Sucralfate 1Sodium-Glucose Transporter 2 Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × tegaserod × Other × Clear all
NCT00399659 2012-05-01

Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.

Novartis

Phase 3 Terminated
360 enrolled
Other

Opioid-Induced Constipation, Constipation

NCT00414024 2012-04-20

Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.

Novartis

Phase 3 Terminated
11 enrolled
Other

Opioid-Induced Constipation, Constipation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡